Navigation Links
Silence Therapeutics Issued Novel RNAi Patent Covering High-Value Cancer Target in United States
Date:5/25/2010

LONDON, May 26 /PRNewswire/ -- Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company") announces the issuance of United States patent 7,723,316, titled Compositions and Methods of RNAi Therapeutics For Treatment of Cancer and Other Neovascularization Disease, by the United States Patent and Trademark Office (USPTO).  The issued patent, which deepens the Company's diverse portfolio of RNA interference (RNAi) intellectual property, is broadly directed to a double-stranded short interfering RNA (siRNA) sequence that targets vascular endothelial growth factor receptor 2 (VEGFR2).  VEGFR2 has been demonstrated to play an important role in the vasculogenic and angiogenic activities that contribute to the development and progression of tumors associated with a broad range of cancers.  The issued subject matter is not limited to the VEGFR2 compositions and also includes methods for reducing tumor growth.

"Silence is compiling a powerful portfolio of intellectual property with value tied to the unique scope of its issued claims and not simply a large number of owned patents.  Today's patent issuance fits perfectly with this strategy, as in our opinion, there are few disease targets with IP value comparable to VEGFR2," stated Philip Haworth, Ph.D., chief executive officer of Silence Therapeutics.  "With its demonstrated connection to a broad host of cancers, among other disease areas, VEGFR2 is a target that we expect to help drive the expansion of Silence's RNAi therapeutics pipeline.  We view today's milestone as more than just another patent issuance; it is a development that significantly enhances the fundamental usefulness and functionality of our growing RNAi IP estate."

The specific composition of matter and method cl
'/>"/>

SOURCE Silence Therapeutics plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Silence Therapeutics and AstraZeneca Announce Collaboration to Develop Novel Approaches for siRNA Drug Delivery
2. FDA Approves Quark IND for DGFi, an siRNA Therapeutic Based on Silence Therapeutics Unique Proprietary Chemistry
3. Silence Therapeutics Announces Successful Opposition of Glover Patent
4. Organizational Changes at Silence Therapeutics
5. Silence Obtains Important Patent Protection for Lead Internal Development Compound, Atu027
6. Silence Therapeutics Patent Update
7. Silence Therapeutics Receives Allowance from United States Patent and Trademark Office for its Core RNAi Patent
8. National Ovarian Cancer Coalition and PureOlogy to Host First Annual NOCC and PureOlogys Walk to Break the Silence on Ovarian Cancer
9. Silence Therapeutics to Present at 12th Annual BIO CEO & Investor Conference
10. Silence Therapeutics Appoints New Vice President of Research
11. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/18/2014)... (PRWEB) October 18, 2014 The ... defines and segments the bio-based advanced phase change ... of revenue. , Browse through the TOC of ... report to get an idea of the in-depth ... the segmentation in the Asia-Pacific bio-based advanced phase ...
(Date:10/18/2014)... October 18, 2014 The Asia-Pacific hardware ... market in Asia-Pacific with analysis and forecast of revenue. ... is expected to reach $51,362.6 million by 2018, at ... Browse through the TOC of the Asia-Pacific hardware encryption ... analysis provided. This also provides a glimpse of the ...
(Date:10/18/2014)... The Biomass Power industry ... years to 2014. The industry's expansion has been propelled ... that encouraged the use of biomass power. Furthermore, the ... which require local utilities to generate electricity from renewable ... Increased campaigning for green technology also influenced industry performance ...
(Date:10/18/2014)... The “Global Diagnostic Electrocardiograph (ECG) Market by Product ... Research Center, Physician Office, Nursing Homes), by Lead ... provides a detailed overview of the major drivers, ... impacting the global diagnostic ECG market along with ... share analysis. , The global diagnostic ECG market ...
Breaking Biology Technology:The Asia-Pacific Bio-based Advanced Phase Change Materials Market is estimated to grow to $39.8 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific Bio-based Advanced Phase Change Materials Market is estimated to grow to $39.8 million by 2018 - New Report by MicroMarket Monitor 3The Asia-Pacific Bio-based Advanced Phase Change Materials Market is estimated to grow to $39.8 million by 2018 - New Report by MicroMarket Monitor 4The Asia-Pacific hardware encryption display market is expected to reach $51,362.6 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific hardware encryption display market is expected to reach $51,362.6 million by 2018 - New Report by MicroMarket Monitor 3Biomass Power in the US Industry Market Research Report from IBISWorld Has Been Updated 2Biomass Power in the US Industry Market Research Report from IBISWorld Has Been Updated 3The Electrocardiograph (ECG) Market Is Expected to Reach $5,435 Million By 2020 - New Research Report by MarketsandMarkets 2The Electrocardiograph (ECG) Market Is Expected to Reach $5,435 Million By 2020 - New Research Report by MarketsandMarkets 3The Electrocardiograph (ECG) Market Is Expected to Reach $5,435 Million By 2020 - New Research Report by MarketsandMarkets 4The Electrocardiograph (ECG) Market Is Expected to Reach $5,435 Million By 2020 - New Research Report by MarketsandMarkets 5
... IL I didnt realize the depth of the task in ... together a Midwest list of public and private biotech companies. Because ... Illinois, which is the center of the Midwest. , ,A year ... 300 biotech companies in the Midwest with about 10 percent of ...
... industry accolades, dont think for a moment that Silicon ... its laurels. , ,Three days before its Altix 3000 family ... by Linux Journal Magazine, SGI rolled out the latest version ... system. The same day, the Mountain View-based company, whose only ...
... When the subject of training is discussed with small ... beyond the discussion phase. Training should be the cornerstone ... Microsoft, Hewlett-Packard, IBM, Cisco Systems, Intel, etc., training takes ... technology moves so quickly your skill sets can become ...
Cached Biology Technology:ePrairie Uncovers 80 Biotech Companies in Illinois 2ePrairie Uncovers 80 Biotech Companies in Illinois 3ePrairie Uncovers 80 Biotech Companies in Illinois 4ePrairie Uncovers 80 Biotech Companies in Illinois 5ePrairie Uncovers 80 Biotech Companies in Illinois 6ePrairie Uncovers 80 Biotech Companies in Illinois 7ePrairie Uncovers 80 Biotech Companies in Illinois 8ePrairie Uncovers 80 Biotech Companies in Illinois 9ePrairie Uncovers 80 Biotech Companies in Illinois 10ePrairie Uncovers 80 Biotech Companies in Illinois 11ePrairie Uncovers 80 Biotech Companies in Illinois 12ePrairie Uncovers 80 Biotech Companies in Illinois 13ePrairie Uncovers 80 Biotech Companies in Illinois 14ePrairie Uncovers 80 Biotech Companies in Illinois 15ePrairie Uncovers 80 Biotech Companies in Illinois 16ePrairie Uncovers 80 Biotech Companies in Illinois 17SGI, Introduces Powerful High End Visualization Tools 2SGI, Introduces Powerful High End Visualization Tools 3The Big Differentiator, Training! 2
(Date:10/15/2014)... Rosenstiel Award for Distinguished Work in Biomedical Science by ... of genomic instability and its implications for the immune ... to win the Rosenstiel Award; the first, Rod McKinnon, ... the Charles A. Janeway Professor of Pediatrics and Professor ... at the Howard Hughes Medical Institute at Boston Children,s ...
(Date:10/14/2014)... of years since T. rex took its ... scientists is breathing life back into dinosaurs using high-powered ... research has important implications for how dinosaurs used their ... sense of smell and cool their brains. , ... student Jason Bourke, lead author of the new study ...
(Date:10/14/2014)... 2014 – High doses of fish oil supplements, rich in ... type of irregular heartbeat in which the heart can beat ... the AFFORD trial led by the Montreal Heart Institute were ... Cardiology on October 7th. , For the trial, 337 ... randomly assigned to 4 grams of fish oil a day ...
Breaking Biology News(10 mins):Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt 2Dinosaur breathing study shows that noses enhanced smelling and cooled brain 2Dinosaur breathing study shows that noses enhanced smelling and cooled brain 3
... or cod caught in the North Sea but declared as ... of fraud in the fisheries sector. A European Commission report ... genomics, chemistry and forensics - can provide clear answers to ... from.where was this fish caught.is it wild or farmed?". The ...
... this study, conducted in Germany, re-open the debate on ... patients in the placebo-group are at a serious disadvantage ... analysed current study designs, for new therapies such as ... that patients in the placebo group experienced no change ...
... published in the current (May 27) edition of the journal ... that concluded that a bacterial bloom in the Gulf of ... The debate has implications for the Gulf of Mexico ... global warming, said marine scientist and lead author Samantha Joye, ...
Cached Biology News:What fish is on your plate? 2Science paper argues against conclusion that bacteria consumed Deepwater Horizon methane 2Science paper argues against conclusion that bacteria consumed Deepwater Horizon methane 3